表紙
市場調査レポート

分子診断:技術および世界市場

Molecular Diagnostics: Technologies and Global Markets

発行 BCC Research 商品コード 63238
出版日 ページ情報 英文 179 pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
分子診断:技術および世界市場 Molecular Diagnostics: Technologies and Global Markets
出版日: 2015年06月22日 ページ情報: 英文 179 pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

当レポートでは、世界の分子診断市場について調査分析し、世界市場の動向、市場の実績データ・推計・CAGR予測、規制・医療費償還・患者機密保持などの関連する問題、科学的な問題、および主要企業プロファイルなどもまとめその結果をお届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 概要
  • ゲノム診断のイントロダクション
  • 発現プロファイルと疾病
  • 発現プロファイルと感染症
  • ジェノタイピング・診断のためのDNAシーケンス
  • 臨床薬理
  • 変異検出・特定遺伝子のジェノタイピング
  • 新疾患遺伝子の特定

第4章 規制・財源

  • 概要
  • 保険
  • 食品と薬剤投与のガイドライン
  • 遺伝子診断のための内部標準
  • 臨床検査室改善法(CLIA)
  • オーダーメイド医療・コンパニオン診断

第5章 商用市場の動向

  • 市況
  • 成功のための新しい要件

第6章 分子診断市場:技術別

  • 概要
  • マイクロアレイ
  • PCR
  • In situ ハイブリダイゼーション(ISH)
  • ラボオンチップ/バイオチップ
  • 新興・その他の診断技術

第7章 分子診断市場:アプリケーション別

  • 概要
  • 出生前・新生児遺伝子スクリーニング
  • 感染症診断
  • 癌診断
  • 身元鑑定(法医学・親子鑑定)
  • 薬理ゲノミクス/その他のアプリケーション

第8章 特許分析

  • PCR
  • アレイ
  • ISH
  • バイオチップ
  • 新興技術 他

第9章 企業プロファイル

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BIO063C

The global molecular diagnostics market was valued at almost $21.7 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2015 through 2020 to reach nearly $25.2 billion by 2015 and $45.2 billion by 2020.

This report provides:

  • An overview of the global market for molecular diagnostics.
  • Analyses of global market trends, with data from 2012, 2013 and 2014 estimates for 2015, and projections of CAGRs through 2020.
  • Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
  • Identification of scientific challenges and advances, including the latest trends in the market.
  • A relevant patent analysis.
  • Comprehensive company profiles of major players in the field of molecular diagnostics.

image1

REPORT SCOPE

SCOPE OF REPORT

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life sciences applications. While the goal of all DNA-based diagnostic assays is similar, several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current market status and presents forecasts of growth over the next five years. Scientific challenges and advances including the latest trends are emphasized. We examine government regulations, major collaborations, recent patents and factors affecting the industry globally. In addition, we examine new directions for DNA diagnostic technologies and emerging applications in clinical diagnostics.

ANALYST'S CREDENTIALS

Jon Evans has been involved in business development and research for the medical industry since 1984. Mr. Evans' career includes four years as a diagnostic systems sales representative and more than 15 years in market research and strategy analysis with Fortune 500 clients. He has developed expertise in assessing the unique business development challenges facing firms in the medical industry and designing strategies to optimize market performance. Mr. Evans received a BS in biology from Rutgers University in 1983, and an MBA in business analysis from San Francisco State University in 1989.

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • FORECASTS
  • SUMMARY TABLE GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2012-2020 ($ MILLIONS)
  • VENDORS

CHAPTER 3 OVERVIEW

  • OVERVIEW
  • INTRODUCTION TO GENOMIC DIAGNOSTICS
  • EXPRESSION PROFILING AND DISEASE
  • EXPRESSION PROFILING AND INFECTIOUS DISEASE
  • DNA SEQUENCING FOR GENOTYPING AND DIAGNOSIS
  • CLINICAL PHARMACOLOGY
  • MUTATION DETECTION AND GENOTYPING FOR SPECIFIC GENES
  • IDENTIFICATION OF NEW DISEASE GENES

CHAPTER 4 REGULATIONS AND FINANCE

  • OVERVIEW
  • INSURANCE
  • FOOD AND DRUG ADMINISTRATION GUIDELINES
  • INTERNAL STANDARDS FOR DNA DIAGNOSTICS
  • TABLE 1 MINIMUM INFORMATION ABOUT A MICROARRAY EXPERIMENT - MIAME 2.0
  • TABLE 2 MICROARRAY QUALITY CONTROL (MAQC) PROJECT
  • CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA)
  • TABLE 3 U.S. LABORATORIES CLIA-CERTIFIED FOR MOLECULAR DIAGNOSTICS AND NUMBER OF DISEASE TESTS, 2012
  • FIGURE 1 GROWTH IN CLINICAL LABORATORY SITES AND DISEASE TESTING, 1993-2015
  • TABLE 4 GENETIC TESTING PROCEDURES PERFORMED IN U.S. BY TYPE, 2015
  • PERSONALIZED MEDICINES AND COMPANION DIAGNOSTICS
    • FDA GUIDELINES FOR IN VITRO COMPANION DIAGNOSTICS
      • Definition and Use of an IVD Companion Diagnostic Device
      • Review and Approval of IVD Companion Diagnostic Devices and Therapeutic Products
        • Novel Therapeutic Products
        • Approval of a Therapeutic Product without an Approved IVD Companion Diagnostic Device
        • General Policies
    • FDA-APPROVED COMPANION DIAGNOSTICS
    • TABLE 5 FDA-APPROVED IN VITRO COMPANION DIAGNOSTIC DEVICES AS OF DEC. 23, 2014
    • TABLE 6 FDA-APPROVED IN VITRO COMPANION DIAGNOSTIC DEVICES, AS OF DECEMBER 2012
    • PHARMACOGENOMICS RESEARCH NETWORK
    • TABLE 7 CURRENT PGRN-RIKEN CGM COLLABORATIVE STUDIES

CHAPTER 5 COMMERCIAL MARKET TRENDS

  • MARKET CONDITIONS
    • HEALTHCARE, HOSPITALS, DOCTORS, GREATER REGULATION AND NEED FOR INSURANCE REIMBURSEMENT
  • NEW REQUIREMENTS FOR SUCCESS
    • SALES AND MARKETING
    • MEDICAL AFFAIRS
    • REGULATORY COMPLIANCE
    • REIMBURSEMENT
    • ALLIANCES AND MERGERS
    • TABLE 8 DIAGNOSTICS MANUFACTURER MERGERS AND ACQUISITIONS, 2004-2014

CHAPTER 6 MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY

  • OVERVIEW
    • DESCRIPTION
    • REVENUES AND FORECASTS
    • TABLE 9 GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 10 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2015 (%)
    • FIGURE 2 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2015 (%)
    • MANUFACTURERS
    • TABLE 11 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY MANUFACTURER, 2015 (%)
    • FIGURE 3 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY MANUFACTURER, 2015 (%)
  • MICROARRAY
    • DESCRIPTION
      • Planar
      • Bead
    • REVENUES AND FORECASTS
    • TABLE 12 GLOBAL MICROARRAY MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 13 GLOBAL MICROARRAY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 4 GLOBAL MICROARRAY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • MANUFACTURERS AND PRODUCTS
      • Planar
      • TABLE 14 MAJOR SUPPLIERS OF PLANAR DNA MICROARRAYS
      • Bead
      • TABLE 15 MAJOR SUPPLIERS OF BEAD MICROARRAYS
  • PCR
    • DESCRIPTION
    • REVENUES AND FORECASTS
    • TABLE 16 GLOBAL PCR MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 17 GLOBAL PCR MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 5 GLOBAL PCR MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • MANUFACTURERS AND PRODUCTS
    • TABLE 18 GLOBAL PCR MARKET SHARE BY MANUFACTURER, 2015 (%)
    • IN SITU HYBRIDIZATION (ISH)
    • DESCRIPTION
      • Labeling Techniques
      • Applications of In Situ Hybridization
    • FIBER FISH
    • HER2 FISH TESTING
    • REVENUES AND FORECASTS
    • TABLE 19 GLOBAL ISH MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 20 GLOBAL ISH MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 6 GLOBAL ISH MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • LAB-ON-A-CHIP/BIOCHIPS
    • DESCRIPTION
      • Microfluidic Devices
    • PRODUCT DEVELOPMENT
    • REVENUES AND FORECASTS
    • TABLE 21 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 22 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 7 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • EMERGING AND OTHER DIAGNOSTIC TECHNOLOGIES
    • DESCRIPTION
      • The Trend toward Single-Cell Measurements
        • Genetic Typing of Single Cells
        • Single-Cell Sequencing
        • Copy Number Variations in Single Cells
        • Combined Immunotyping and Single-Cell Expression Analysis
        • Diagnosing the Epigenome
    • REVENUES AND FORECASTS
    • TABLE 23 GLOBAL EMERGING/OTHER MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 24 GLOBAL EMERGING/OTHER MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATION, 2015 (%)

CHAPTER 7 MARKETS FOR MOLECULAR DIAGNOSTICS BY APPLICATION AND PRODUCTS

  • OVERVIEW
    • DESCRIPTION
    • REVENUES AND FORECASTS
    • TABLE 25 GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 26 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 8 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • PRE-/POSTNATAL GENETIC SCREENING
    • DESCRIPTION
      • Carrier Screening
      • Prenatal Diagnostic Testing
      • Amniocentesis
      • Chorionic Villus Sampling
      • Genetic Counseling
      • Preimplantation Diagnosis
      • Newborn Screening
    • REVENUES AND FORECASTS
    • TABLE 27 GLOBAL PRE/POSTNATAL SCREENING MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 28 GLOBAL PRE/POSTNATAL SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 9 GLOBAL PRE/POSTNATAL SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • INFECTIOUS DISEASE DIAGNOSTICS
    • DESCRIPTION
    • REVENUES AND FORECASTS
    • TABLE 29 GLOBAL INFECTIOUS DISEASES MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 30 GLOBAL INFECTIOUS DISEASE SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 10 GLOBAL INFECTIOUS DISEASE SCREENIN MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • ONCOLOGY DIAGNOSTICS
    • DESCRIPTION
      • Leukemias
        • Chronic Myeloid Leukemia
          • Genetic Marker of Chronic Myeloid Leukemia
    • REVENUES AND FORECASTS
    • TABLE 31 GLOBAL ONCOLOGY MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 32 GLOBAL ONCOLOGY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 11 GLOBAL ONCOLOGY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • IDENTITY DIAGNOSTICS, FORENSICS AND PATERNITY
    • DESCRIPTION
      • Paternity Testing
      • Technology
      • Accreditation
      • Legal Issues
      • Veterinary Identity Testing
    • REVENUES AND FORECASTS
    • TABLE 33 GLOBAL IDENTITY TESTING MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 34 GLOBAL IDENTITY TESTING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • FIGURE 12 GLOBAL IDENTITY TESTING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
    • PHARMACOGENOMICS/OTHER APPLICATIONS
    • DESCRIPTION
    • REVENUES AND FORECASTS
    • TABLE 35 GLOBAL PHARMACOGENOMICS AND OTHER MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 36 GLOBAL PHARMACOGENOMICS AND OTHER MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)

CHAPTER 8 PATENT ANALYSIS

  • PCR
  • TABLE 37 SELECTED PCR PATENTS GRANTED FROM JANUARY 2013 TO JANUARY 2015
  • REAL TIME PCR DETECTION OF RESPIRATORY SYNCYTIAL VIRUS
  • NUCLEIC ACID AMPLIFICATION PRIMERS FOR PCR-BASED CLONALITY STUDIES
  • QUANTITATIVE MULTIPLEX METHYLATION SPECIFIC PCR METHOD- CMETHDNA, REAGENTS, AND ITS USE
  • REAL-TIME PCR DETECTION OF STREPTOCOCCUS PYOGENES
  • REAL-TIME PCR FOR THE DETECTION OF PATHOGENS
  • QUANTITATIVE MULTIPLEX METHYLATION-SPECIFIC PCR
  • REAL-TIME PCR DETECTION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX
  • REAL TIME PCR DETECTION OF M. TUBERCULOSIS RESISTANT/SUSCEPTIBLE TO RIFAMPICIN AND/OR ISONIAZID
  • ABSOLUTE PCR QUANTIFICATION
  • COMPOSITIONS AND METHOD FOR MEASURING AND CALIBRATING AMPLIFICATION BIAS IN MULTIPLEXED PCR REACTIONS
  • REAL-TIME PCR DETECTION OF SEASONAL INFLUENZA H1, H3 AND B SUBTYPES
  • MULTIMODAL PCR TARGET DETECTION
  • COMPOSITION TO OVERCOME INHIBITORS IN PCR AND GROWTH CULTURES
  • MAGNETIC IMMUNO DIGITAL PCR ASSAY
  • CUTOFF POINT DELTA CT. METHOD FOR HER2 PCR TESTING IN BREAST CANCER
  • METHODS AND COMPOSITIONS FOR PCR USING BLOCKED AND UNIVERSAL PRIMERS
  • PCR ASSAYS AND REAGENTS FOR MOLECULAR DETECTION OF INFECTIOUS AGENTS
  • RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR
  • MICRO RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF OVARIAN CANCER USING A REAL-TIME PCR PLATFORM
  • PCR METHODS FOR CHARACTERIZING THE 5' UNTRANSLATED REGION OF THE FMR1 AND FMR2 GENES
  • MULTIPLEX PCR-BASED TESTING OF CUTANEOUS SQUAMOUS CELL CARCINOMA AND PSEUDOEPITHELIOMATOUS HYPERPLASIA AND METHODS FOR DISTINGUISHING THE SAME
  • IDENTIFICATION OF ANTIGEN-SPECIFIC ADAPTIVE IMMUNE RESPONSES USING ARM-PCR AND HIGH-THROUGHPUT SEQUENCING
  • QUANTITATIVE MULTIPLEX METHYLATION-SPECIFIC PCR
  • PCR DIAGNOSTICS OF DERMATOPHYTES AND OTHER PATHOGENIC FUNGI
  • HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS
  • SINGLE TUBE QUANTITATIVE POLYMERASE CHAIN REACTION (PCR)
  • HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS
  • IDENTIFICATION OF LINKAGE USING MULTIPLEX DIGITAL PCR
  • METHODS AND COMPOSITIONS TO ENABLE MULTIPLEX COLD-PCR
  • METHODS OF DIAGNOSING DISEASE USING OVERLAP EXTENSION PCR
  • HOT-START DIGITAL PCR
  • METHOD FOR DETECTION, DIFFERENTIATION AND QUANTIFICATION OF T CELL POPULATIONS BY WAY OF REVERSE TRANSCRIPTION QUANTITATIVE REAL TIME PCR (RT-QPCR) TECHNOLOGY
  • NDM-1 POLYMERASE CHAIN REACTION (PCR) ASSAY
  • DETECTION OF MICRO METASTASIS OF MELANOMA AND BREAST CANCER IN PARAFFIN-EMBEDDED TUMOR DRAINING LYMPH NODES BY MULTIMARKER QUANTITATIVE RT-PCR
  • LATE-PCR
  • HEMOMOSAIC: HIGH-THROUGHPUT TECHNIQUE FOR RARE CELL DETECTION IN LIQUID SAMPLES BY MASSIVELY MULTIPLEXED PCR IN A PHOTOLITHOGRAPHIC MATRIX
  • SERIAL QUANTITATIVE PCR ASSAY FOR DETECTION, SPECIES-DISCRIMINATION AND QUANTIFICATION OF LEISHMANIA SPP. IN HUMAN SAMPLES
  • GENE DETECTING METHODS WITHOUT USING PCR
  • HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS
  • PROCESS FOR DETECTION OF MULTIDRUG RESISTANT TUBERCULOSIS USING REAL-TIME PCR AND HIGH RESOLUTION MELT ANALYSIS
  • ISOFORMS OF THE HUMAN SST5 RECEPTOR ORIGINATED BY ALTERNATIVE SPLICING AND OLIGONUCLEOTIDE PAIRS TO DETECT THEM BY PCR
  • REAL TIME PCR ASSAY FOR DETECTION OF BACTERIAL RESPIRATORY PATHOGENS
  • METHODS AND COMPOSITIONS RELATED TO CONTINUOUS FLOW THERMAL GRADIENT PCR
  • METHOD FOR DETECTING MORE THAN ONE TARGET IN A PCR-BASED APPROACH APPLYING AN UN-SPECIFIC DYE WHICH IS NOT INTERFERING WITH THE EMISSION OF FLUOROPHORE-LABELED PROBES
  • MICROARRAY
  • TABLE 38 SELECTED MICROARRAY PATENTS GRANTED, JANUARY 2013 TO MAY 2015
  • METHODS AND SYSTEMS FOR MANUFACTURE OF MICROARRAY ASSAY SYSTEMS, CONDUCTING MICROFLUIDIC ASSAYS, AND MONITORING AND SCANNING TO OBTAIN MICROFLUIDIC ASSAY RESULTS
  • SYMMETRICALLY BRANCHED POLYMER CONJUGATES AND MICROARRAY ASSAYS
  • TWO-DIMENSIONAL PHOTONIC CRYSTAL MICROARRAY MEASUREMENT METHOD AND APPARATUS FOR HIGHLY-SENSITIVE LABEL-FREE MULTIPLE ANALYTE SENSING, BIOSENSING, AND DIAGNOSTIC ASSAY
  • SOURCE CONTROLLED DECODABLE MICROARRAY SYSTEM AND METHODS FOR USE
  • MICROARRAY BASED SAMPLE DETECTION SYSTEM
  • MICROARRAY FABRICATION SYSTEM AND METHOD
  • MICROARRAY FOR DETECTING VIABLE ORGANISMS
  • SERUM-BASED MIRNA MICROARRAY AND ITS USE IN DIAGNOSIS AND TREATMENT OF BARRETT'S ESOPHAGUS (BE) AND ESOPHAGEAL ADENOCARCINOMA (EAC)
  • LUMINOPHORE-LABELED MOLECULES COUPLED WITH PARTICLES FOR MICROARRAY-BASED ASSAYS
  • Y-SHAPED PROBE AND VARIANT THEREOF, AND DNA MICROARRAY, KIT AND GENETIC ANALYSIS METHOD USING THE SAME
  • MICROARRAY-BASED ASSAY INTEGRATED WITH PARTICLES FOR ANALYZING MOLECULAR INTERACTIONS
  • MICROARRAY FABRICATION SYSTEM AND METHOD
  • ALLERGEN MICROARRAY
  • PHOTONIC CRYSTAL MICROARRAY LAYOUTS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF LABEL-FREE MULTIPLE ANALYTE SENSING, BIOSENSING AND DIAGNOSTIC ASSAY
  • ISH
  • TABLE 39 SELECTED ISH PATENTS GRANTED, JANUARY 2013 TO MAY 2015
  • CELL PREPARATIONS AND CELL SUPPORTS AND THEIR USE IN THERANOSIS
  • ULTRA SENSITIVE METHOD FOR IN SITU DETECTION OF NUCLEIC ACIDS
  • BACH2 REPRESSION IN CELLS
  • IN SITU HYBRIDIZATION METHOD AND BUFFER
  • BIOCHIP
  • TABLE 40 SELECTED BIOCHIP PATENTS GRANTED, JANUARY 2013 TO MAY 2015
  • BIOCHIP AND TARGET DNA QUANTITATIVE METHOD
  • UNITARY BIOCHIP PROVIDING SAMPLE-IN TO RESULTS-OUT PROCESSING AND METHODS OF MANUFACTURE
  • BIOCHIP AND FABRICATION THEREOF
  • UNITARY BIOCHIP PROVIDING SAMPLE-IN TO RESULTS-OUT PROCESSING AND METHODS OF MANUFACTURE
  • BIOCHIP ASSEMBLY AND ASSAY METHOD THEREOF
  • BIOCHIP

CHAPTER 9 COMPANY PROFILES

  • ABBOTT MOLECULAR 135
    • PRODUCT CATEGORIES
    • PARTNERSHIPS
  • ADVANDX INC.
  • AFFYMETRIX INC.
    • PRODUCTS
      • Agrigenomics Genotyping Solutions
      • Chromogenic RNA in situ Hybridization
      • Fluorescence RNA in situ Hybridization
  • AGILENT TECHNOLOGIES INC.
    • PRODUCTS
    • PCR/qPCR
  • AUTOGENOMICS INC.
    • PRODUCTS
  • BECKMAN COULTER INC. (OWNED BY DANAHER)
    • PRODUCTS
      • Pipeline
    • BECTON DICKINSON AND COMPANY
  • BIOMERIEUX SA
    • PRODUCTS
      • Argene Molecular Biology Range
  • BIO-RAD LABORATORIES
    • LIFE SCIENCE RESEARCH
    • CLINICAL DIAGNOSTICS
    • PRODUCTS
      • Amplification/PCR
      • Digital PCR
      • PrimePCR Assays and Panels
      • Real-Time PCR Detection Systems
      • Thermal Cyclers
      • PX1 PCR Plate Sealer
      • PCR Reagents
      • PCR Plastic Consumables
      • Amplification Software
      • Nucleic Acid Sample Preparation and Purification
  • CALIPER LIFE SCIENCES INC.
    • PRODUCTS
      • Microfluidics, Laboratory Automation and Liquid Handling
  • THE CARLYLE GROUP
  • CEPHEID
    • PRODUCTS
  • CURAGEN CORP. (ACQUIRED BY CELLDEX)
  • DECODE GENETICS
    • PRODUCTS AND SERVICES
  • DNA DIAGNOSTICS CENTER
    • SERVICES
  • ELITECH GROUP
  • EMD MILLIPORE
    • PRODUCTS
  • EUROGENTEC (OWNED BY KANEKA CORP.)
    • PRODUCTS
    • SERVICES
  • EXACT SCIENCES CORP.
  • GE HEALTHCARE
  • HOLOGIC INC.
    • PRODUCTS
  • HTG MOLECULAR DIAGNOSTICS
    • SERVICES
    • PRODUCTS
  • ILLUMINA
    • PRODUCTS
  • LABORATORY CORP. OF AMERICA (LABCORP)
  • LIFE TECHNOLOGIES
    • PRODUCTS
  • LUMINEX CORP
    • PRODUCTS
      • xMAP technology
      • xTAG Technology
      • MultiCode Technology
  • MICRONICS INC.
    • PRODUCTS
  • MYRIAD GENETICS
    • PRODUCTS
    • PRODUCTS IN DEVELOPMENT
  • NOVARTIS MOLECULAR DIAGNOSTICS
    • PRODUCTS
      • Development Strategy
      • Novartis Diagnostics Division Products
  • OXFORD GENE TECHNOLOGY IP LTD.
    • PRODUCTS
  • PATHOGENETIX
  • PROMEGA
  • QIAGEN N.V.
    • PRODUCTS
  • COMPANION DIAGNOSTICS
  • QUEST DIAGNOSTICS
    • PRODUCTS
  • IN DEVELOPMENT
  • ROCHE
  • TABLE 41 ROCHE-COMPANION DIAGNOSTICS PIPELINE JOINT ONCOLOGY PHARMA AND DIAGNOSTICS
  • SAVYON DIAGNOSTICS
    • PRODUCTS
  • SEQUENOM INC.
    • PRODUCTS
    • APPLICATIONS
  • SIEMENS
  • SORENSON GENOMICS INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TRANSGENOMIC INC.
    • PRODUCTS AND PIPELINES
      • Genetic Testing Services
      • In Development

LIST OF TABLES

  • SUMMARY TABLE GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
  • TABLE 1 MINIMUM INFORMATION ABOUT A MICROARRAY EXPERIMENT - MIAME 2.0
  • TABLE 2 MICROARRAY QUALITY CONTROL (MAQC) PROJECT
  • TABLE 3 U.S. LABORATORIES CLIA-CERTIFIED FOR MOLECULAR DIAGNOSTICS AND NUMBER OF DISEASE TESTS, 2012
  • TABLE 4 GENETIC TESTING PROCEDURES PERFORMED IN U.S. BY TYPE, 2015
  • TABLE 5 FDA-APPROVED IN VITRO COMPANION DIAGNOSTIC DEVICES AS OF DEC. 23, 2014
  • TABLE 6 FDA-APPROVED IN VITRO COMPANION DIAGNOSTIC DEVICES, AS OF DECEMBER 2012
  • TABLE 7 CURRENT PGRN-RIKEN CGM COLLABORATIVE STUDIES
  • TABLE 8 DIAGNOSTICS MANUFACTURER MERGERS AND ACQUISITIONS, 2004-2014
  • TABLE 9 GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
  • TABLE 10 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2015 (%)
  • TABLE 11 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY MANUFACTURER, 2015 (%)
  • TABLE 12 GLOBAL MICROARRAY MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 13 GLOBAL MICROARRAY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 14 MAJOR SUPPLIERS OF PLANAR DNA MICROARRAYS
  • TABLE 15 MAJOR SUPPLIERS OF BEAD MICROARRAYS
  • TABLE 16 GLOBAL PCR MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 17 GLOBAL PCR MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 18 GLOBAL PCR MARKET SHARE BY MANUFACTURER, 2015 (%)
  • TABLE 19 GLOBAL ISH MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 20 GLOBAL ISH MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 21 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 22 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 23 GLOBAL EMERGING/OTHER MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 24 GLOBAL EMERGING/OTHER MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATION, 2015 (%)
  • TABLE 25 GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 26 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 27 GLOBAL PRE/POSTNATAL SCREENING MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 28 GLOBAL PRE/POSTNATAL SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 29 GLOBAL INFECTIOUS DISEASES MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 30 GLOBAL INFECTIOUS DISEASE SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 31 GLOBAL ONCOLOGY MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 32 GLOBAL ONCOLOGY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 33 GLOBAL IDENTITY TESTING MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • TABLE 34 GLOBAL IDENTITY TESTING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 35 GLOBAL PHARMACOGENOMICS AND OTHER MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS) 13
  • TABLE 36 GLOBAL PHARMACOGENOMICS AND OTHER MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • TABLE 37 SELECTED PCR PATENTS GRANTED FROM JANUARY 2013 TO JANUARY 2015
  • TABLE 38 SELECTED MICROARRAY PATENTS GRANTED, JANUARY 2013 TO MAY 2015
  • TABLE 39 SELECTED ISH PATENTS GRANTED, JANUARY 2013 TO MAY 2015
  • TABLE 40 SELECTED BIOCHIP PATENTS GRANTED, JANUARY 2013 TO MAY 2015
  • TABLE 41 ROCHE-COMPANION DIAGNOSTICS PIPELINE JOINT ONCOLOGY PHARMA AND DIAGNOSTICS

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2012-2020 ($ MILLIONS)
  • FIGURE 1 GROWTH IN CLINICAL LABORATORY SITES AND DISEASE TESTING, 1993-2015
  • FIGURE 2 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2015 (%)
  • FIGURE 3 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY MANUFACTURER, 2015 (%)
  • FIGURE 4 GLOBAL MICROARRAY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 5 GLOBAL PCR MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 6 GLOBAL ISH MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 7 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 8 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 9 GLOBAL PRE/POSTNATAL SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 10 GLOBAL INFECTIOUS DISEASE SCREENIN MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 11 GLOBAL ONCOLOGY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
  • FIGURE 12 GLOBAL IDENTITY TESTING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
Back to Top